Marker Therapeutics
Oumar Diouf, currently serving as the Senior Director of CMC at Marker Therapeutics, Inc., has extensive experience in the pharmaceutical industry. Previously, at Cell Medica, Diouf held the position of Director of Manufacturing and PD. Diouf holds a Master of Business Administration (MBA) degree and a Bachelor of Science (BS) degree in Biotechnology from the University of Houston-Downtown.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.